A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

By Song Hong   Do Young   Chang Heung   Ryu Min   Lee Kyung   Kim Yeul   Hong Dae   Cho Jae   Lee Kyoung   Kim Si  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 763-768

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Gemcitabine, UFT and Leucovorin in Patients with Advanced Pancreatic Cancer

By Kim Tae Won   Kang Hae Jin   Ahn Jin Hee   Lee Keehyun   Chang Heung Moon   Kang Yoon Koo   Lee Jung Shin  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 689-694

Informa Healthcare

Access to resources Recommend Favorite

A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma

By Park Byeong-Bae   Park Joon   Lee Hyo   Lee Jeeyun   Choi Dong   Choi Seong-Ho   Heo Jin   Lee Jong   Lee Kyu   Lim Do   Park Young   Lim Ho-Yeong   Kang Won   Park Keunchil  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 489-494

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study*

By Conte P.F.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 2, 2001-07 ,pp. : 171-179

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer

By Ko Andrew   Venook Alan   Bergsland Emily   Kelley R.   Korn W.   Dito Elizabeth   Schillinger Brian   Scott Janet   Hwang Jimmy   Tempero Margaret  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1051-1057

Springer Publishing Company

Access to resources Recommend Favorite